Please assess the completion status of the following clinical trial:

Trial Title: Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Has undergone abdominoplasty with no additional collateral procedures.~* Experiences a pain intensity rating of moderate to severe acute pain.~* Able to provide written informed consent before any study procedure.~Exclusion Criteria:~* ASA Physical Status Classification System classification of P3 or worse.~* Has surgical or post-surgical complications.~* Has clinically significant medical conditions or history of such conditions that may interfere with the interpretation of efficacy, safety, or tolerability data obtained in the trial, or may interfere with the absorption, distribution, metabolism, or excretion of drugs.~* Has previously participated in another TRV130 clinical study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Treatment 1 Oliceridine (Type: EXPERIMENTAL): None
- Treatment 2 Oliceridine (Type: EXPERIMENTAL): None
- Treatment 3 Oliceridine (Type: EXPERIMENTAL): None
- Treatment 4 Placebo (Type: PLACEBO_COMPARATOR): None
- Treatment 5 Morphine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).